HC Wainwright Maintains Buy Rating on Alto Neuroscience, Sets $60 Target
HC Wainwright maintained its Buy rating and $60 price target on Alto Neuroscience. The target implies 173.5% upside from the Oct. 16 close of $21.94.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.